Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

CODXBullishCorporate Developmentsnews

High materiality8/10

Co-Diagnostics Expands TB Test Distribution, Market Opportunities Increase

Mar 25, 2026, 8:06 AM EDT1 sourcesAI-analyzed

Why it may matterVerify against the original reporting

The positive market reaction (7.93% increase) coupled with expansion in key markets creates upward momentum for CODX, reflecting confidence in future revenue growth akin to previous expansions.

AI summary

What happened, with direct paths to the underlying reporting

Co-Diagnostics has initiated shipments for tuberculosis (TB) test studies in India, expanding its market reach across South Asia through a new partnership. This move aligns with WHO guidance and suggests strong growth potential, likely benefiting CODX's stock performance in the short term.

Co-Diagnostics begins shipments for TB clinical performance studies in India.
A partnership expands distribution across South Asia, enhancing market reach.
WHO guidelines support Co-Diagnostics’ testing alignment with their PCR platform.
Encouraging preclinical results for TB test support further clinical evaluation.
Co-Diagnostics stock rose 7.93% to $2.45 in premarket trading.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Co-Diagnostics Expands TB Test Distribution, Market Opportunities Increase

Co-Diagnostics Expands South Asian Market Reach for PCR Products

Penny Stock Co-Diagnostics Withdraws FDA Application For COVID-19 Test, Plans To Submit Enhanced Version